Last edition
News about "inflammatory diseases"
Sanofi Names Montpellier Global Hub for Autoimmune Disease Research
Sanofi, in partnership with the Immun4Cure University Hospital Institute in Montpellier, has launched a Translational Centre of Excellence focused on developing treatments for autoimmune and inflammatory diseases. The centre aims to place patients at the core of R&D, spanning early research through advanced clinical trials.
Inflammatory Diseases | 16/10/2025 | By Dineshwori | 107
Merck Expands Tulisokibart Phase-2(b) Trials Across Three Inflammatory Diseases
Tulisokibart is an investigational anti-TL1A monoclonal antibody currently in Phase-3 trials for Ulcerative Colitis and Crohn’s disease, to be studied in hidradenitis suppurativa, radiographic axial spondyloarthritis and Rheumatoid Arthritis.
Inflammatory Diseases | 07/10/2025 | By Dineshwori | 160
Accro Bioscience and Fosun Pharma Enter Licensing Deal for AC-201 in Greater China
Accro Bioscience has granted Fosun Pharma exclusive rights to develop, manufacture, and commercialise AC-201 — its independently developed, highly selective TYK2/JAK1 inhibitor — in Greater China (including the Chinese Mainland, Hong Kong SAR, and Macau SAR).
Inflammatory Diseases | 01/09/2025 | By Dineshwori | 137
Matchpoint, Novartis Partner to Develop Oral Inhibitors for Multiple Inflammatory Diseases
Matchpoint Therapeutics has entered into an exclusive option and license agreement with Novartis to develop and commercialise oral covalent inhibitors for multiple inflammatory diseases.
Inflammatory Diseases | 28/07/2025 | By Dineshwori | 113
Evox Therapeutics Appoints Dr. Per Lundin as Chief Executive Officer
Evox Therapeutics Ltd. has announced the appointment of Dr. Per Lundin, Co-Founder and Chief Business Officer as Chief Executive Officer (CEO) and will be appointed to its Board of Directors.
Inflammatory Diseases | 30/04/2024 | By Aishwarya | 764
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy